CX Stock Analysis: Cemex SAB de CV | NYSE
Building Materials | NYSE, USA | Market Cap: 15.771m USD | 12M Return: 8.2% | US1512908898 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 73.6M
EPS Trend: 76.6%
Qual. Beats: 0
Rev. Trend: 7.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cemex is a Mexico-based global producer of cement, ready-mix concrete, aggregates, and related construction materials, headquartered in San Pedro Garza García. Founded in 1906 and listed on the NYSE in 1999, the company sells a wide range of cement grades, specialty concrete mixes, crushed stone and sand products, and urbanization and waste-management solutions, including its low-carbon Vertua line.
The company operates in the Materials sector, specifically Construction Materials. Cement and aggregates are high-volume, low-margin products, so proximity of production facilities to end markets is a key competitive factor in the industry, and demand is closely tied to housing, commercial, and infrastructure construction cycles.
- US infrastructure spending lifts cement volumes and pricing
- Energy costs pressure cement margins amid volatile input prices
- Mexico construction demand and peso swings drive reported results
| Net Income: 628.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.40 > 1.0 |
| NWC/Revenue: -1.97% < 20% (prev -3.61%; Δ 1.64% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.80b > Net Income 628.9m |
| Net Debt (6.38b) to EBITDA (3.77b): 1.69 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (145.8m) vs 12m ago -90.09% < -2% |
| Gross Margin: 32.76% > 18% (prev 32.06%; Δ 0.70% > 0.5%) |
| Asset Turnover: 60.96% > 50% (prev 54.45%; Δ 6.50% > 0%) |
| Interest Coverage Ratio: 3.57 > 6 (EBIT TTM 1.64b / Interest Expense TTM 459.8m) |
| A: -0.01 (Total Current Assets 6.03b - Total Current Liabilities 6.37b) / Total Assets 28.0b |
| B: 0.25 (Retained Earnings 6.88b / Total Assets 28.0b) |
| C: 0.06 (EBIT TTM 1.64b / Avg Total Assets 28.5b) |
| D: 0.87 (Book Value of Equity 12.9b / Total Liabilities 14.8b) |
| Altman-Z'' = 2.03 = BBB |
| DSRI: 1.02 (Receivables 3.00b/2.68b, Revenue 17.4b/15.8b) |
| GMI: 0.98 (GM 32.06% / 32.76%) |
| AQI: 0.97 (AQ_t 0.37 / AQ_t-1 0.38) |
| SGI: 1.10 (Revenue 17.4b / 15.8b) |
| TATA: -0.08 (NI 628.9m - CFO 2.80b) / TA 28.0b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of November 10, 2026, the stock is trading at USD 11.09 with a total of 10,046,925 shares traded. Over the past week, the price has changed by +1.84%, over one month by +16.00%, over three months by -1.57% and over the past year by +8.17%.
Current recommended Stop Loss: 10.20 (which is 8% or 2.6 ATR below the current price).
Cemex SAB de CV has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy CX.
- StrongBuy: 6
- Buy: 6
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.8 | 33.5% |
P/E Trailing = 68.3125
P/E Forward = 12.3916
P/S = 0.9073
P/B = 1.1845
P/EG = 0.1074
Revenue TTM = 17.4b USD
EBIT TTM = 1.64b USD
EBITDA TTM = 3.77b USD
Long Term Debt = 4.90b USD (from longTermDebt, last quarter)
Short Term Debt = 445.6m USD (from shortTermDebt, last quarter)
Debt = 7.03b USD (from shortLongTermDebtTotal, last quarter) + Leases 959.0m
Net Debt = 6.38b USD (calculated: Debt 7.03b - CCE 652.0m)
Enterprise Value = 22.2b USD (15.8b + Debt 7.03b - CCE 652.0m)
Interest Coverage Ratio = 3.57 (Ebit TTM 1.64b / Interest Expense TTM 459.8m)
EV/FCF = 11.55x (Enterprise Value 22.2b / FCF TTM 1.92b)
FCF Yield = 8.66% (FCF TTM 1.92b / Enterprise Value 22.2b)
FCF Margin = 11.04% (FCF TTM 1.92b / Revenue TTM 17.4b)
Net Margin = 3.62% (Net Income TTM 628.9m / Revenue TTM 17.4b)
Gross Margin = 32.76% ((Revenue TTM 17.4b - Cost of Revenue TTM 11.7b) / Revenue TTM)
Gross Margin QoQ = 35.47% (prev 35.22%)
Tobins Q-Ratio = 0.79 (Enterprise Value 22.2b / Total Assets 28.0b)
Interest Expense / Debt = 6.54% (Interest Expense 459.8m / Debt 7.03b)
Taxrate = 42.18% (518.4m / 1.23b)
NOPAT = 947.8m (EBIT 1.64b * (1 - 42.18%))
Current Ratio = 0.95 (Total Current Assets 6.03b / Total Current Liabilities 6.37b)
Debt / Equity = 0.55 (Debt 7.03b / totalStockholderEquity, last quarter 12.9b)
Debt / EBITDA = 1.69 (Net Debt 6.38b / EBITDA 3.77b)
Debt / FCF = 3.33 (Net Debt 6.38b / FCF TTM 1.92b)
Total Stockholder Equity = 13.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.21% (Net Income 628.9m / Total Assets 28.0b)
RoE = 4.85% (Net Income TTM 628.9m / Total Stockholder Equity 13.0b)
RoCE = 9.17% (EBIT 1.64b / Capital Employed (Equity 13.0b + L.T.Debt 4.90b))
RoIC = 4.43% (NOPAT 947.8m / Invested Capital 21.4b)
WACC = 7.73% (E(15.8b)/V(22.8b) * Re(9.49%) + D(7.03b)/V(22.8b) * Rd(6.54%) * (1-Tc(0.42)))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -63.45 | Cagr: -64.17%
[DCF] Terminal Value 77.97% ; FCFF base≈1.55b ; Y1≈1.78b ; Y5≈2.62b
[DCF] Fair Price = 22.87 (EV 39.4b - Net Debt 6.38b = Equity 33.0b / Shares 1.44b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 76.60 | EPS CAGR: 24.46% | SUE: 0.18 | # QB: 0
Revenue Correlation: 7.26 | Revenue CAGR: 0.27% | SUE: 0.65 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.14 | Chg30d=-6.67% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=0.82 | Chg30d=+1.83% | Revisions=-40% | GrowthEPS=+57.3% | GrowthRev=+8.1%
EPS next Year (2027-12-31): EPS=0.89 | Chg30d=-1.22% | Revisions=-40% | GrowthEPS=+9.3% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: -38% (up=1, down=4)